Recombinant
RabMAb

Anti-delta 1 Catenin (phospho Y228) antibody [E205] (ab32403)

Publishing research using ab32403? Please let us know so that we can cite the reference in this datasheet.

ab32403 has been referenced in 2 publications.

  • Surana R  et al. IL4 limits the efficacy of tumor-targeted antibody therapy in a murine model. Cancer Immunol Res 2:1103-12 (2014). WB . PubMed: 25204776
  • Ma LW  et al. Phosphorylated p120-catenin expression has predictive value for oral cancer progression. J Clin Pathol 65:315-9 (2012). PubMed: 22259181

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up